PDCD1 and neoplasm: It is known that blocking immune checkpoint receptors such as PD-1/PD-L1 and CTLA-4 can alleviate CD8+T cell exhaustion and reactivate immune cell cytotoxicity to eliminate antigen-expressing tumor cells (20).